Moderna’s Stock Soars As US Government Pours Millions Into Secret Bird Flu Vaccine Trials
Moderna’s stock surges as the US government invests millions in covert bird flu vaccine trials, amid concerns over H5N1’s spread and potential human-to-human transmission ahead of the presidential elections. In the New York premarket trading session, Moderna’s shares have increased by nearly 4% in response to a Financial Times report